| In recent years,near-infrared light-responsive theranostics have drawn attention owing to their simplicity,safety,non-invasiveness,high selectivity and targeting properties.Bismuth(Bi)-based nanoagents possess wide application prospects in the area of tumor theranostics owing to their excellent electrical,optical and thermodynamic properties.Based on this,we have designed and prepared four Bi-based near-infrared(NIR)light-responsive nanoplatform and analyzed their structural and functional properties.Besides,we investigated the imaging and synergistic anti-tumor therapeutic effects of these multi-functional nanoplatforms at the cellular and animal level,and discussed the internal mechanism of their theranostics effects,hoping to provide evidence and theoretical frames for subsequent development of tumor precise treatments.Firstly,we designed a smart theranostics nanoplatform based on a hyaluronic acid-doped polypyrrole-coated bismuth selenide loading with a zinc phthalocyanine nanodish complex(Bi2Se3@HA-doped PPy/Zn Pc)for multimodal imaging-guided combined anti-tumor phototherapy.Besides the good ability for infrared thermal,photoacoustic,fluorescence,and X-ray computed tomography imaging,the nanodish complex exhibited high photo-heat conversion efficiency for photothermal therapy(PTT),as well as remarkable optical absorption of the coefficient for photodynamic therapy(PDT)under NIR irradiation.However,hyperthemia(>50°C)induced heating damage of nearby normal organs and inflammatory diseases are the main challenges for PTT of tumors.To overcome this limitation,Bi2Se3 hollow nanocubes(HNCs),redox-responsive biomodal tumor-targeted nanoplatforms,were first fabricated.The Bi2Se3 HNCs were then modified with hyaluronicacid(HA)through redox-cleavable linkage(-s-s-)and loaded by gambogic acid(GA),which was a type of heat-shock protein(HSP)inhibitor.Such HNC-s-s-HA/GA could achieve multi-spectral optoacoustic tomography/X-ray computed tomography imaging-guided low-temperature photothermal-radio combined therapy(PTT-RT).In addition,although PTT can take advantages of local hyperthermia to ablate tumor cells,its effect on metastatic tumor cells is still limited.To overcome these obstacles,an imiquimod(R848)loaded and PEG-modified Bi2Se3 nanocage(NC),which could efficiently destroy the tumors thus producing enough tumor-associated antigens(TAA)was reported in this study.What’s more,with the existence of R848,a toll-like receptor-7 agonist,this nanoplatform could generate strong anti-tumor immune responses to realize tomur immunotherapy.Moreover,immunogenic Bi2Se3NC-PEG/R848 mediated PTT sensitized tumors to checkpoint inhibition mediated by a PD-L1 antibody,which could not only ablate tumor cells upon NIR laser,but also cause strong anti-tumor immunity to suppress distant tumor growth post-PTT.Moreover,due to the highly complex biological formation procedure,tumor is always associated with proliferation,migration and inflammation during treatment.Herein,a novel strategy of boosted photocatalytic activity induced nicotinamide phosphoribosyl transferase(NAMPT)-regulating therapy was used for tumor inhibition based on FK866 loaded bismuth-humic acids heterojunction(Bi-HA/FK866).The reactive oxygen species(ROS)produced by Bi-HA/FK866 with the existence of NIR could induce DNA damage of the tumor cells,thus enhancing the sensitivity to the inhibitor of NAMPT(FK866)to downregulate nicotinamide adenine dinucleotide/extracellular regulated protein kinases/nuclear factor kappa-B(NAD/ERK/NF-κB)signal pathways,and eventually simultaneously preventing tumor progression.Moreover,the decreased NAD could reduce the expression of nicotinamide adenine dinucleotide phosphate(NADPH)and further suppress the innate antioxidant defense system by downregulating oxidized glutathione(GSSG). |